Literature DB >> 11788585

Changes in the mechanism of DNA integration in vitro induced by base substitutions in the HIV-1 U5 and U3 terminal sequences.

Elena Brin1, Jonathan Leis.   

Abstract

We have reconstituted concerted human immunodeficiency virus type 1 (HIV-1) integration with specially designed mini-donor DNA, a supercoiled plasmid acceptor, purified bacterial-derived HIV-1 integrase (IN), and host HMG-I(Y) protein (Hindmarsh, P., Ridky, T., Reeves, R., Andrake, M., Skalka, A. M., and Leis, J. (1999) J. Virol. 73, 2994-3003). Integration in this system is dependent upon the mini donor DNA having IN recognition sequences at both ends and the reaction products have all of the features associated with integration of viral DNA in vivo. Using this system, we explored the relationship between the HIV-1 U3 and U5 IN recognition sequences by analyzing substrates that contain either two U3 or two U5 terminal sequences. Both substrates caused severe defects to integration but with different effects on the mechanism indicating that the U3 and the U5 sequences are both required for concerted DNA integration. We have also used the reconstituted system to compare the mechanism of integration catalyzed by HIV-1 to that of avian sarcoma virus by analyzing the effect of defined mutations introduced into U3 or U5 ends of the respective wild type DNA substrates. Despite sequence differences between avian sarcoma virus and HIV-1 IN and their recognition sequences, the consequences of analogous base pair substitutions at the same relative positions of the respective IN recognition sequences were very similar. This highlights the common mechanism of integration shared by these two different viruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788585     DOI: 10.1074/jbc.M108116200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Biochemical and biophysical analyses of concerted (U5/U3) integration.

Authors:  Duane P Grandgenett; Sibes Bera; Krishan K Pandey; Ajaykumar C Vora; Jacob Zahm; Sapna Sinha
Journal:  Methods       Date:  2008-11-29       Impact factor: 3.608

3.  Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.

Authors:  Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

4.  Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.

Authors:  Sapna Sinha; Duane P Grandgenett
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences.

Authors:  Elena Brin; Jonathan Leis
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

6.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

7.  DNA Physical Properties and Nucleosome Positions Are Major Determinants of HIV-1 Integrase Selectivity.

Authors:  Monica Naughtin; Zofia Haftek-Terreau; Johan Xavier; Sam Meyer; Maud Silvain; Yan Jaszczyszyn; Nicolas Levy; Vincent Miele; Mohamed Salah Benleulmi; Marc Ruff; Vincent Parissi; Cédric Vaillant; Marc Lavigne
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.